For many years, CD23 has been a reliable marker that is widely used to differentiate between B-LPDs, in particular CLL and MCL as it is positive in CLL and negative in MCL [36, 37]. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.